Get 36% Off on Vitamins D3 and K2 90-Day Supply Get 36% Off on Vitamins D3 and K2 90-Day Supply


Kratom Drug Ban May Cripple Promising Painkiller Research

A ban on kratom, a plant that the U.S. Drug Enforcement Administration (DEA) says it intends to ban as soon as September 30, may stop promising painkiller research in its tracks, reports Scientific American.

I’ve reported many times on the antiquated rules the DEA and Health and Human Services (HHS) are invoking to deny people from using safe, effective painkillers instead of pharmaceutical products such as oxycontin, which is linked to thousands of overdoses and deaths every year.

Both kratom and medicinal marijuana offer positive alternatives to prescription drugs and the street drug — heroin — that people are seeking for pain relief. But marijuana, and now kratom, remain out of reach for the majority of people, due to problems at the federal level, where products like marijuana are classified as a Schedule 1 controlled substance.

Schedule 1 drugs are defined as those having a "high potential for abuse" and "no acceptable medical use in treatment," even though research shows that marijuana meets neither of these criteria. For example, studies show that medical cannabis stimulates appetite in AIDS patients, reduces neuropathic pain in multiple sclerosis (MS) patients, reduces and/or eliminates epilectic seizures and has even been used in Israel to treat cancer, epilepsy and Parkinson’s disease.

While we wait for the DEA to enter this century, there are natural ways to address your pain and avoid surgery, including sitting less and employing relaxation techniques such as expressive writing and the emotional freedom technique, which can help you “tap” your way out of chronic pain.
Click Here and be the first to comment on this article
Post your comment